SciClone Appoints CFO

Wilson W. Cheung has been appointed chief financial officer and senior vice president of finance at SciClone Pharmaceuticals, Inc. Mr. Cheung is an experienced senior financial and international accounting executive with broad experience spanning financial management, SEC and SOX 404 financial reporting for publicly traded international companies, as well as corporate governance and compliance, operations management, corporate development and investor relations. Mr. Cheung will report to Friedhelm Blobel, Ph.D., chief executive officer, and will be based in the company’s Foster City, CA headquarters.
 
Mr. Cheung most recently served as chief compliance officer, Asia Pacific of Velti plc, a global mobile marketing and advertising SaaS provider. Mr. Cheung was also chief financial officer and corporate secretary at AXT, Inc., a manufacturer of high performance semiconductor substrates, with a major presence in China, where he led the finance and operations teams. He previously held senior financial positions at InterWAVE Communications International, Yahoo!, Deloitte, and KPMG.
 
“Wilson has extensive experience in managing financial operations and compliance for commercial, publicly traded companies and has a deep understanding of companies operating in China in highly regulated, competitive and fast changing environments,” said Dr. Blobel. “His international, multi-industry experience will be especially valuable as our company implements strategies to expand the market opportunities for ZADAXIN, develop the potential of our growing portfolio of products, and strengthen our standing as a U.S.-based, China-focused specialty pharmaceutical company.”